Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00483834
Recruitment Status : Completed
First Posted : June 7, 2007
Last Update Posted : February 15, 2019
Hoffmann-La Roche
Information provided by (Responsible Party):
University Health Network, Toronto